Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stockholm - Delayed Quote SEK

Ortivus AB (publ) (ORTI-A.ST)

3.0795
+0.2295
+(8.05%)
At close: April 28 at 9:00:00 AM GMT+2
Loading Chart for ORTI-A.ST
  • Previous Close 2.8500
  • Open 3.0795
  • Bid 2.6400 x --
  • Ask 3.0600 x --
  • Day's Range 3.0795 - 3.0795
  • 52 Week Range 2.5000 - 5.1500
  • Volume 500
  • Avg. Volume 704
  • Market Cap (intraday) 73.9M
  • Beta (5Y Monthly) 0.77
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMed FleetCtrl, a a software application that regular controls, checklists, and documentation tailored for seamless fleet management; MobiMed Life, a heart safe solution. It also provides ambulance services, primary care, and rescue services. The company was incorporated in 1985 and is headquartered in Stockholm, Sweden.

www.ortivus.com

32

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ORTI-A.ST

View More

Performance Overview: ORTI-A.ST

Trailing total returns as of 4/28/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

ORTI-A.ST
8.35%
OMX Stockholm 30 Index (^OMX)
2.22%

1-Year Return

ORTI-A.ST
32.76%
OMX Stockholm 30 Index (^OMX)
5.07%

3-Year Return

ORTI-A.ST
45.01%
OMX Stockholm 30 Index (^OMX)
19.11%

5-Year Return

ORTI-A.ST
30.01%
OMX Stockholm 30 Index (^OMX)
54.80%

Compare To: ORTI-A.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ORTI-A.ST

View More

Valuation Measures

Annual
As of 4/25/2025
  • Market Cap

    64.82M

  • Enterprise Value

    95.57M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.57

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    1.13

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -30.97%

  • Return on Assets (ttm)

    -17.45%

  • Return on Equity (ttm)

    -491.18%

  • Revenue (ttm)

    80.41M

  • Net Income Avi to Common (ttm)

    -24.9M

  • Diluted EPS (ttm)

    -0.5600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.28M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -9.73M

Research Analysis: ORTI-A.ST

View More

Company Insights: ORTI-A.ST

Research Reports: ORTI-A.ST

View More

People Also Watch